Sign up
Pharma Capital
EPIC: AGL
Market: AIM
Sector: Pharma & Biotech
Market Cap: 75.33M
Website: www.angleplc.com

ANGLE PLC develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of disease.

ANGLE PLC

www.angleplc.com

Interactive graph

col 3
col 4
col 5
col 6

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.